N/A N=99 An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
Uterine Fibroid · Arteriovenous Malformations · Hypervascular Tumors
Primary: Procedural Success — 70; 16; 7; 6 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=35 Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma
Asthma · Gastroesophageal Reflux
Primary: Change in Asthma Control Questionnaire (ACQ) From Screening Through Week 26 — -0.5; -0.6 score on a scale — p=0.8716
Phase 4 N=10 Impact of Semaglutide on CD34+ EPC and Fat Derived MSC
Diabetes Mellitus, Type 2
Primary: CD34+ Endothelial Progenitor Cell Number (EPC) Per Mononuclear Cells (MNC) Ratio — 0.10; 0.23; 0.12; 0.13 ratio
N/A N=102 Medication Adherence in Rheumatic Diseases
Chronic Rheumatic Diseases
Primary: Intervention Feasibility as Measured by Number of Providers Agreeing to Participate — 6 Participants
Phase 3 N=195 Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate
Advanced Prostate Cancer · Metastatic Prostate Cancer · Locally Advanced Prostate Cancer
Primary: Percentage of Participants Who Achieved Castrate Levels of Serum Testosterone on Day 29 — 99.5 percentage of participants
Phase 2 N=147 A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder
Binge-Eating Disorder
Primary: Change From Baseline in Number of Binge Eating Days Per Week — -3.44; -3.07; -3.01 binge eating days per week — p=0.1893
N/A N=10 Musical Engagement of Brain LObes in Alzheimer's Disease Patients StudY
Alzheimer Disease · Dementia · Music Therapy
Primary: Changes in Intervention Response as Evaluated by the Clinical Global Impression of Change (CGIC) — 0; 0; 5; 2 Participants
N/A N=72 Using Neuroeconomics to Characterize State-Based Increases and Decreases in Alcohol Value
Alcohol Use Disorder · Alcohol Drinking
Primary: Alcohol Demand Intensity — 7.42; 7.85 Drinks
Phase 2 N=328 A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
Glabellar Lines
Primary: Percentage of Participants With Achievement of ≥ 1-grade Improvement From Baseline as Rated by Investigator Using the Clinician Glabellar Lines Scale. — 17.8; 95.6…
Phase 2 N=6 An Open-label Safety, Pharmacokinetic, and Efficacy Study of Miglustat for the Treatment of Subjects With Batten Ceroid Lipofuscinosis, Neuronal 3 (CLN3) Disease
Batten Disease
Primary: Number of Treatment-emergent Adverse Events. — 6 Participants
Phase 3 N=264 Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-2)
Nasal Polyps
Primary: Change From Baseline in Total Endoscopic Nasal Polyps (NP) Score at Week 52 (Centrally Read) — -0.5; 0.1 Scores on scale — p=0.004
N/A N=66 Group Telehealth Weight Management Visits for Adolescents With Obesity
Obesity, Childhood
Primary: Mean Change From Baseline to 6 Months in Body Mass Index — 1.07; 0.17 kilograms by the square of their height
N/A N=52 Gait Re-education Program in Subjects With Parkinson´s Disease
Parkinson Disease
Primary: Physical Performance: The Short Physical Performance Battery (SPPB) — 8.78; 9.60; 8.89; 10.72 units on a scale
N/A N=29 Using Mobile Technology to Address the Trauma Mental Health Treatment Gap
Post Traumatic Stress Disorder
Primary: Aim 1: Evaluation of Educational Materials — 3; 2; 4; 2 Participants
N/A N=764 Assessment of Individual Risk of Cardiovascular Events by Platelet FcGammaRIIa
STEMI · NSTEMI
Primary: Ischemic — 2.09; 2.71; 3.24; 2.57 Hazard Ratio comparing high and low pFCG